Research Site

White River Junction, Vermont 05009

1 studies enrolling now · 6 studies all time

What they study most

Anemia, Cancer, Cardiovascular Disease, Colon Cancer, Colorectal Cancer, Dyslipidemia, Heart Failure, Lung Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, Rectal Cancer

Studies at this site

• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors — Completed
• Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy — Stopped early
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed